Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.
Camille VongMartin BoucherSteve RileyLutz O HarnischPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)
NCT01994889 (date of registration: November 26, 2013).